排序方式:
    總頁 1 
      Go

    1.Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis

    Hu, HT, Pan, HD, Li,     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2022, Volume 13,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 17  2022影響因子:  5.6  发表年影響因子:  5.6 

    2.A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells

    Han, Y, Qu, YQ, Mok,     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2019, Volume 10,

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  5.6  发表年影響因子:  4.225 

    3.The calcium-induced regulation in the molecular and transcriptional circuitry of human inflammatory response and autoimmunity

    de Seabra Rodrigues     More...

    Frontiers in Pharmacology[1663-9812], Published 2018, Volume 8, Issue JAN,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 15  2022影響因子:  5.6  发表年影響因子:  3.845 

    4.Identification of a novel protein arginine methyltransferase 5 inhibitor in non-small cell lung cancer by structure-based virtual screening

    Wang, Qianqian, Xu,     More...

    Frontiers in Pharmacology[1663-9812], Published 2018, Volume 9, Issue MAR,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 19  2022影響因子:  5.6  发表年影響因子:  3.845 

    5.A Method for Rapid Screening of Anilide-Containing AMPK Modulators Based on Computational Docking and Biological Validation

    Mok, SWF, Zeng, W, N     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2018, Volume 9, Issue JUL,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 10  2022影響因子:  5.6  发表年影響因子:  3.845 

    6.Gossypol Inhibits Non-small Cell Lung Cancer Cells Proliferation by Targeting EGFRL(858R/T790M)

    Wang, YW, Lai, HL, F     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2018, Volume 9, Issue JUL,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 14  2022影響因子:  5.6  发表年影響因子:  3.845 

    7.Krukovine Suppresses KRAS-Mutated Lung Cancer Cell Growth and Proliferation by Inhibiting the RAF-ERK Pathway and Inactivating AKT Pathway

    Lai, HL, Wang, YW, D     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2018, Volume 9, Issue AUG,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 18  2022影響因子:  5.6  发表年影響因子:  3.845 

    8.Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2

    Xu, P, Zhou, H, Li,     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2018, Volume 9, Issue OCT,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 16  2022影響因子:  5.6  发表年影響因子:  3.845 

    9.N-Desmethyldauricine Induces Autophagic Cell Death in Apoptosis-Defective Cells via Ca2+ Mobilization

    Law, BYK, Mok, SWF,     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2017, Volume 8, Issue JUN,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 21  2022影響因子:  5.6  发表年影響因子:  3.831 

    10.Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells

    Luo, LX, Li, Y, Liu,     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2017, Volume 8, Issue APR,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 43  2022影響因子:  5.6  发表年影響因子:  3.831 

    11.Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells

    Xie, C, Li, Y, Li, L     More...

    FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2017, Volume 8, Issue NOV,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 32  2022影響因子:  5.6  发表年影響因子:  3.831 

    顯示      條  合計   11   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫